Journalartikel

Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPH


AutorenlisteWiedenroth, Christoph B.; Bandorski, Dirk; Ariobi, Kanischka; Ghofrani, H-Ardeschir; Lankeit, Mareike; Liebetrau, Christoph; Pruefer, Diethard; Mayer, Eckhard; Kriechbaum, Steffen D.; Guth, Stefan

Jahr der Veröffentlichung2022

Seiten663-670

ZeitschriftThe Thoracic and Cardiovascular Surgeon

Bandnummer70

Heftnummer08

ISSN0171-6425

eISSN1439-1902

DOI Linkhttps://doi.org/10.1055/s-0041-1740559

VerlagThieme Publishing / Georg Thieme Verlag


Abstract
Background The gold standard treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA). Little is known about the influence of advanced age on surgical outcome. Therefore, the aim of this study was to investigate the impact of patient's age on postoperative morbidity, mortality, and quality of life in a German referral center. Methods Prospectively collected data from 386 consecutive patients undergoing PEA between 01/2014 and 12/2016 were analyzed. Patients were divided into three groups according to their age: group 1: <= 50 years, group 2: > 50 <= 70 years, group 3: > 70 years. Results After PEA, distinct improvements in pulmonary hemodynamics, physical capacity (World Health Organization [WHO] functional class and 6-minute walking distance) and quality of life were found in all groups. There were more complications in elderly patients with longer time of invasive ventilation, intensive care, and in-hospital stay. However, the in-hospital mortality was comparable (0% in group 1, 2.6% in group 2, and 2.1% in group 3 [ p = 0.326]). Furthermore, the all-cause mortality at 1 year was 1.1% in group 1, 3.2% in group 2, and 6.3% in group 3 ( p = 0.122). Conclusions PEA is an effective treatment for CTEPH patients of all ages accompanied by low perioperative and 1-year mortality. CTEPH patients in advanced age carefully selected by thorough preoperative evaluation should be offered PEA in expert centers to improve quality of life, symptoms, and pulmonary hemodynamics.


Zitierstile

Harvard-ZitierstilWiedenroth, C., Bandorski, D., Ariobi, K., Ghofrani, H., Lankeit, M., Liebetrau, C., et al. (2022) Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPH, The Thoracic and Cardiovascular Surgeon, 70(08), pp. 663-670. https://doi.org/10.1055/s-0041-1740559

APA-ZitierstilWiedenroth, C., Bandorski, D., Ariobi, K., Ghofrani, H., Lankeit, M., Liebetrau, C., Pruefer, D., Mayer, E., Kriechbaum, S., & Guth, S. (2022). Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPH. The Thoracic and Cardiovascular Surgeon. 70(08), 663-670. https://doi.org/10.1055/s-0041-1740559



Schlagwörter


ANGIOPLASTYCOMPLICATIONSoutcomes (includes mortality morbidity)Pulmonary embolismPulmonary vascular resistance


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:18